Pfizer’s Comirnaty: Emerging Myocarditis Signal Drew Flurry Of Attention During Compressed BLA Review

 
• By Sue Sutter
Drug Review Profile: Comirnaty
US FDA's Review of Pfizer/BioNTech SE’s COVID-19 vaccine became unexpectedly more complicated mid-cycle with the emergence the myocarditis side effect.

More from Drug Review Profiles

More from Product Reviews